Advertisement
Canada markets closed
  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     
  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     
  • DOW

    37,903.29
    +87.37 (+0.23%)
     
  • CAD/USD

    0.7284
    +0.0023 (+0.32%)
     
  • CRUDE OIL

    79.13
    -2.80 (-3.42%)
     
  • Bitcoin CAD

    79,274.25
    -3,438.42 (-4.16%)
     
  • CMC Crypto 200

    1,202.07
    -136.99 (-10.23%)
     
  • GOLD FUTURES

    2,330.20
    +27.30 (+1.19%)
     
  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     
  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     
  • NASDAQ futures

    17,474.75
    -96.50 (-0.55%)
     
  • VOLATILITY

    15.39
    -0.26 (-1.66%)
     
  • FTSE

    8,121.24
    -22.89 (-0.28%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • CAD/EUR

    0.6794
    -0.0008 (-0.12%)
     

Stocks in play: ProMIS Neurosciences, Inc.

Announced that its lead product candidate for Alzheimer's disease, PMN310, showed similar ability to ...

Announced that its lead product candidate for Alzheimer's disease, PMN310, showed similar ability to cross the blood brain barrier and penetrate the central nervous system, compared to aducanumab. ProMIS Neurosciences, Inc.